The world's first commercialized biota microbial mass spectrometry database has been released worldwide.

On July 18, Qingdao Science and Technology Bureau announced that the Qingdao Institute of Technology in the incubation enterprise Fusion Biotech (Qingdao) Co., Ltd. has completed a microbial mass spectrometry database based on the new biohism concept.
this is the first time that a commercialbiomic microbial mass spectrometry database has been published worldwide.
, the matrix-assisted laser ionizing flight time mass spectrometry (MALDI-TOF MS) has been widely used in Europe and the United States and other developed countries, as well as China's triple-A hospitals, provincial and municipal food safety regulatory agencies.
mass spectrometry that combines this method is known in the industry as microbial mass spectrometry. One of the core of the
microbial mass spectrometry technology is the construction of microbial mass spectrometry database.
it is understood that the traditional method of building a library is expensive, to build a database of 4000 species, need hundreds of millions of dollars of funds.
and globally dispersed, it is very difficult to collect and identify so many species specimens, and there are currently only a few thousand microbes available for microbial mass spectrometry identification.
more importantly, microbial specimens are important biomass information resources with strategic sensitivity.
therefore, the academic community has begun to explore the construction of a microbial mass spectrometry database based on biocomposition.
innovative use of the new microbial database concept, through the combination of biohismatic information, supported by unique data algorithms, the high lysopia identification microbial database (QuanID) efficiently built.
with advanced scientific instruments and life science background, the micro-organisms innovatively used the new microbial database concept, changed the traditional library construction process, recently completed the quanID microbial database construction.
, through the combination of biohismatic information, with the support of unique data algorithms, efficiently build a mass spectrometry identification microbial database.
to date, the QuanID Microbial Database has been built a large microbial mass spectrometry database containing more than 4,000 microorganisms (bacteria, fungi) covering clinical, food safety, animal husbandry and veterinary medicine, environmental ecology and scientific research.
after clinical, disease control, food safety, aquaculture and animal husbandry and other industries nearly 10,000 samples of the actual verification, (species, subspecies level) accuracy of more than 95%, to meet the needs of commercialization.
this is another innovative achievement of the spectrometry biota following the launch of the Wide Spectrum Quantitative Flight Time Mass Spectrometry (QuanTOF) platform in 2017.
biocomposition-based microbial database represents the development direction of a new generation of mass spectrometry microbial database, will replace the traditional way of building a library, greatly promote the rapid development of microbial mass spectrometry technology.
future, the biopic will further rapidly expand the microbial database capacity, making microbial mass spectrometry applicable to a wider range of industries.
Rongzhi Biotech (Qingdao) Co., Ltd. introduction led by the two academicians, the national thousand-person plan special experts, is specialized in life science analysis instruments and equipment, supplies and solutions research and development, production, sales, service of the state-level high-tech enterprises, registered capital of 50 million yuan.
company in boston, Beijing, Qingdao, Nanjing and Hangzhou in the United States, the layout of research and development, production, application development, sales, service and other sub-centers, the establishment of academician workstations, with the Chinese Agricultural University, the Chinese Academy of Sciences and other scientific research institutions set up a joint laboratory, and undertaken a number of national and local scientific and technological innovation research and development projects.
as a research and development-oriented high-tech enterprises with independent intellectual property rights, the company has invested more than 50 million yuan in research and development since its establishment, now has a "wide-spectrum quantitative flight time mass spectrometry (a new generation of matrix-assisted laser despliment flight time mass spectrometry)" and "micro-flow control chip nucleic acid rapid analysis" two technical platforms, of which "wide spectrum quantitative flight time mass spectrometry platform" by the two members of the Academy of Sciences identification committee for the "overall performance of the international leading level."
based on two core technology platforms, the organism has developed a series of products such as microbial rapid identification mass spectrometry system, SNP genotype mass spectrometry system, protein quantitative analysis mass spectrometry system, mass spectrometry imaging system, food trace mass spectrometry system, foodborne pathogenic bacteria detection system, respiratory pathogen detection system, avian influenza virus detection system, genetically modified testing system, etc., covering clinical medicine, inspection and quarantine, food safety, disease control and other fields.
company has been CFDA two medical device registration certificate 1, medical device production license 1;
take root at home, look at the international, become an internationally competitive biotechnology enterprise is the business objective of the melting of intelligent organisms, the intelligent organisms will be persistent for the high-end life science instruments localization, the improvement of the level of medical health of the Chinese people to contribute.
.